By Rob Meagher
CBE Press has learned that BioTrackTHC has been awarded the exclusive contract to run New York State’s Seed-to-Sale Tracking system, which includes both the government system and the licensed enterprises in state, and is the first contract in the industry that requires the licensees to use the state’s tracking software solution.
In the three (3) previously state awarded contracts — Colorado (Franwell), and Washington and New Mexico (BioTrack THC) — state licensed producers, processors and retailers have been allowed to choose the software provider that tracks their products and uploads to the state contracted system.
According to the New York State Contract Reporter’s May 22 release, BioTrack bested Agrisoft Development Group, Franwell, Leaf Logix Technology and MJ Freeway. The purpose of the state’s Request for Proposal (RFP) is to seek a contractor to provide a cloud-hosted Seed-to-Sale Tracking Software System for New York State’s Medical Marijuana Program. This system will be utilized by organizations registered with the New York State Department of Health (NYSDOH) to cultivate, manufacture,
distribute and dispense medical marijuana in New York State, as well as provide NYSDOH the ability to access the data of each registered organization.
BioTrack THC is on a roll, winning the last three awarded state contracts as it continues to grow its market share nationally in a race to establish the largest installed base of licensee users with MJ Freeway and other software vendors in the hotly contested seed-to-sale and point of sale software solution space in the cannabis industry.
New York state’s highly restricted medical program will issue licenses to five winners that can grow and sell medical marijuana via as many as four dispensaries each, for a grand total of 20 statewide. The program does not allow for smoking the plant, but, it does allows the sale of oils, edibles, and vapor forms of the drug.
It also limits the amount of qualifying conditions for doctor prescription to HIV/AIDS, Lou Gehrig’s disease, Parkinson’s, Huntington’s disease, epilepsy, some spinal cord injuries, and multiple sclerosis.